A Study to Extend the Registry of Inflammatory Diseases of the Central Nervous System

Overview

About this study

The purpose of this study is to extend enrollment and follow up of participants in a registry for inflammatory diseases of the central nervous system.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Must have a disease of the central nervous system considered by the treating clinician to be inflammatory in nature
- Neuromyelitis optica
- Optic neuritis
- Transverse myelitis
- Paraneoplastic central nervous system disorders
- Multiple sclerosis
- Inflammatory central nervous system diseases not otherwise specified
And must have been a participant in the CNS Repository IRB#08-007846

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Sean Pittock, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Sean Pittock, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials